Related Experiment Video
Updated: Jun 17, 2025
High Efficiency Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes and Characterization by Flow Cytometry
Published on: September 23, 2014
Comparison of Two Differentiation Protocols of Human-Induced Pluripotent Stem Cells into Cardiomyocytes
Agnieszka Łoboda1, Monika Kłaptocz2, Katarzyna Kaziród2
1Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University in Krakow, Kraków, Poland. agnieszka.loboda@uj.edu.pl.
Insights
Human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are crucial for studying heart disease mechanisms and drug development. This study compares two differentiation protocols, finding similar efficiencies but highlighting the need for parameter optimization.
Area of Science:
- Cardiology
- Stem Cell Biology
- Drug Discovery
Background:
- Human-induced pluripotent stem cells (hiPSC-CMs) are valuable for modeling cardiovascular diseases.
- Developing effective differentiation protocols is key for reliable hiPSC-CM applications.
Purpose of the Study:
- To compare the GiWi method and a commercial kit for hiPSC-CM differentiation.
- To identify critical parameters for optimizing hiPSC-CM generation.
Main Methods:
- Comparison of two distinct hiPSC-CM differentiation protocols.
- Optimization of cell density and small molecule concentrations (CHIR-99021, IWR-1).
Main Results:
- Both GiWi and commercial kit protocols achieved similar differentiation efficiencies.
- Optimization of parameters like cell density and small molecule concentration is necessary for functional hiPSC-CMs.
Conclusions:
- The choice between GiWi and commercial kits depends on experimental needs.
- Optimized protocols are essential for generating functional hiPSC-CMs for research and drug screening.
Abstract:
Cardiomyocytes derived from human-induced pluripotent stem cells (hiPSC-CMs) offer an attractive platform to evaluate the mechanisms of cardiovascular-related incidents and to develop and test new drugs for heart diseases. This work focuses on the comparison of two hiPSC-CM differentiation protocols: the GiWi method based on temporal modulation of the Wnt/β-catenin pathway and the commercially available PSC Cardiomyocyte Differentiation Kit. We underlined the need to optimize several parameters such as cell density or small molecule concentration (CHIR-99021, IWR-1) to obtain functional hiPSC-CMs. Both protocols yield a similar differentiation efficiency; therefore, the choice of a particular procedure may depend on the preferences of the experimenter.
More Related Videos
11:13Electrophysiological Analysis of human Pluripotent Stem Cell-derived Cardiomyocytes hPSC-CMs Using Multi-electrode Arrays MEAs
Published on: May 12, 2017
13:18Generation of Human Cardiomyocytes: A Differentiation Protocol from Feeder-free Human Induced Pluripotent Stem Cells
Published on: June 28, 2013
